Hoth Therapeutics, Inc.
Data quality: 83%
HOTH
Nasdaq
Manufacturing
Chemicals
$0.54
▼
$0.02
(-4.04%)
Mkt Cap: 10.32 M
Price
$0.54
Mkt Cap
10.32 M
Day Range
$0.53 — $0.57
52-Week Range
$0.50 — $2.12
Volume
272,314
Open $0.56
50D / 200D Avg
$0.94
42.35% below
50D / 200D Avg
$1.22
55.64% below
Quick Summary
Key Takeaways
Negative free cash flow of -9.80 M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-138.74%
Below sector avg (-53.41%)
ROIC-108.66%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
N/A
Current Ratio8.81
Interest CoverageN/A
Valuation
PE (TTM)
-0.83
Above sector avg (-1.48)
P/B Ratio1.25
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (1364 peers)
Peer Comparison
vs Manufacturing sector median (1364 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -0.8 | -1.5 |
| P/B | 1.3 | 1.6 |
| ROE % | -138.7 | -53.4 |
| Net Margin % | — | -41.5 |
| Rev Growth 5Y % | — | 1.8 |
| D/E | — | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -12.47 M |
| ROE | -138.74% | ROA | -128.87% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -9.80 M |
| ROIC | -108.66% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 8.81 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | 7.91 M | Tangible Book Value | 8.23 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0.83 | Forward P/E | N/A |
| P/B Ratio | 1.25 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -94.99% | ||
| Market Cap | 10.32 M | Enterprise Value | 2.47 M |
| Per Share | |||
| EPS (Diluted TTM) | -0.90 | Revenue / Share | N/A |
| FCF / Share | -0.51 | OCF / Share | -0.51 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 78.62% |
| SBC-Adj. FCF | -11.28 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -12.47 M | -8.19 M | -7.85 M | -11.37 M | -14.31 M |
| EPS (Diluted) | -0.90 | -1.28 | -2.30 | -8.79 | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -12.36 M | -8.22 M | -7.69 M | -11.07 M | -14.10 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 5.95 M | 3.25 M | 3.48 M | 4.84 M | 7.35 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Income Tax | — | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 7.60 M | 7.71 M | 9.52 M | 6.76 M | 10.99 M |
| Total Liabilities | 1.45 M | 833,906.0 | 704,983.0 | 1.64 M | 1.10 M |
| Shareholders' Equity | 6.15 M | 6.88 M | 8.82 M | 5.12 M | 9.88 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 6.25 M | 7.04 M | 9.29 M | 6.43 M | 8.54 M |
| Current Assets | 6.86 M | 7.64 M | 9.43 M | 6.73 M | 10.58 M |
| Current Liabilities | 1.45 M | 831,197.0 | 678,657.0 | 1.39 M | 867,787.0 |
{"event":"ticker_viewed","properties":{"ticker":"HOTH","listing_kind":"stock","pathname":"/stocks/hoth","exchange":"Nasdaq","country":"US"}}